{"id":57639,"date":"2023-08-18T01:58:03","date_gmt":"2023-08-17T16:58:03","guid":{"rendered":"https:\/\/www.theguardian.com\/world\/2023\/aug\/17\/china-renews-crackdown-on-corruption-in-healthcare"},"modified":"2023-08-18T01:58:03","modified_gmt":"2023-08-17T16:58:03","slug":"china-renews-crackdown-on-corruption-in-healthcare","status":"publish","type":"post","link":"https:\/\/eastasianews.net\/wp\/?p=57639","title":{"rendered":"China renews crackdown on corruption in healthcare"},"content":{"rendered":"<p>At least 177 officials reportedly under investigation amid revival of Xi Jinping\u2019s decade-old anti-corruption drive<\/p>\n<p>China\u2019s graft-busters have set their sights on the country\u2019s healthcare sector, in what has been described as the biggest crackdown on corruption in the history of the industry.<\/p>\n<p>At least 177 hospital bosses and Chinese Communist party (CCP) secretaries have been placed under investigation this year according to local media reports \u2013 more than double the number last year. In a press conference on Tuesday, the National Health Commission (NHC) said the campaign would focus on people who had used their position to procure kickbacks and corruption in the pharmaceutical sector, the state tabloid the Global Times reported.<\/p>\n<p> <a href=\"https:\/\/www.theguardian.com\/world\/2023\/aug\/17\/china-renews-crackdown-on-corruption-in-healthcare\">Continue reading&#8230;<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>At least 177 officials reportedly under investigation amid revival of Xi Jinping\u2019s decade-old anti-corruption driveChina\u2019s graft-busters have set their sights on the country\u2019s healthcare sector, in what has been described as the biggest crackdown on co&#8230;<\/p>\n","protected":false},"author":3586,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"sns_share_botton_hide":"","vkExUnit_sns_title":"","_vk_print_noindex":"","sitemap_hide":"","_veu_custom_css":"","veu_display_promotion_alert":"","vkexunit_cta_each_option":"","footnotes":""},"categories":[41,6,50,2875,647,42,49],"tags":[],"class_list":["post-57639","post","type-post","status-publish","format-standard","hentry","category-asia-pacific","category-business","category-china","category-healthcare-industry","category-pharmaceuticals-industry","category-world-news","category-xi-jinping"],"aioseo_notices":[],"veu_head_title_object":{"title":"","add_site_title":""},"_links":{"self":[{"href":"https:\/\/eastasianews.net\/wp\/index.php?rest_route=\/wp\/v2\/posts\/57639","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eastasianews.net\/wp\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eastasianews.net\/wp\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eastasianews.net\/wp\/index.php?rest_route=\/wp\/v2\/users\/3586"}],"replies":[{"embeddable":true,"href":"https:\/\/eastasianews.net\/wp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=57639"}],"version-history":[{"count":1,"href":"https:\/\/eastasianews.net\/wp\/index.php?rest_route=\/wp\/v2\/posts\/57639\/revisions"}],"predecessor-version":[{"id":57640,"href":"https:\/\/eastasianews.net\/wp\/index.php?rest_route=\/wp\/v2\/posts\/57639\/revisions\/57640"}],"wp:attachment":[{"href":"https:\/\/eastasianews.net\/wp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=57639"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eastasianews.net\/wp\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=57639"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eastasianews.net\/wp\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=57639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}